A Phase II, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy of 28 Day Oral Administration of AZD9668 in Patients with Bronchiectasis

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-000753-35

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To investigate whether AZD9668 shows evidence of efficacy in bronchiectasis patients by investigation of: · Absolute and percentage neutrophil cell count in the sputum · Signs and symptoms of bronchiectasis (including effects on quality of life)


Critère d'inclusion

  • Bronchiectasis